Development of a Predictive Model for Type 2 Diabetes Mellitus Using Genetic and Clinical Data  by Lee, Juyoung et al.
Public Health Res Perspect 2011 2(2), 75e82
doi:10.1016/j.phrp.2011.07.005
pISSN 2210-9099 eISSN 2233-6052- ORIGINAL ARTICLE -Development of a Predictive Model for Type 2
Diabetes Mellitus Using Genetic and Clinical DataJuyoung Lee a,*, Bhumsuk Keam b, Eun Jung Jang c, Mi Sun Park d,
Ji Young Lee a, Dan Bi Kim d, Chang-Hoon Lee e, Tak Kim f, Bermseok Oh g,
Heon Jin Park h, Kyu-Bum Kwack i, Chaeshin Chu c, Hyung-Lae Kim j
aDivision of Structural and Functional Genomics, Korea National Institute, Osong, Korea.
bDivision of Biobank for Health Sciences, Korea National Institute, Osong, Korea.
cDivision of Epidemic Intelligence Service, Korea Centers for Disease Control and Prevention,
Osong, Korea.
dDivision of Bio-Medical Informatics, Korea National Institute, Osong, Korea.
eDepartment of Internal Medicine and Lung Institute, Seoul National University College of Medicine,
Seoul, Korea.
fDivision of Quarantine Support, Korea Centers for Disease Control and Prevention, Osong, Korea.
gDepartment of Biomedical Engineering, School of Medicine, Kyung Hee University, Seoul, Korea.
hDepartment of Statistics, Inha University, Incheon, Korea.
iMedical Genomics Laboratory, Pochon CHA University, Seongnam, Korea.
jCenter for Genome Research, Korea Centers for Disease Control and Prevention, Osong, Korea.Received: March 30,
2011
Revised: April 21, 2011






type 2 diabetes mellitus
(T2DM)*Corresponding author.
E-mail: jylee@cdc.go.kr
This is an Open Access article distr
(http://creativecommons.org/licenses/b
any medium, provided the original work
ª 2011, Korea Centers for Disease ContrAbstract
Objectives: Recent genetic association studies have provided convincing
evidence that several novel loci and single nucleotide polymorphisms (SNPs) are
associated with the risk of developing type 2 diabetes mellitus (T2DM). The aims
of this study were: 1) to develop a predictive model of T2DM using genetic and
clinical data; and 2) to compare misclassification rates of different models.
Methods: We selected 212 individuals with newly diagnosed T2DM and 472
controls aged in their 60s from the Korean Genome and Epidemiology Study.
A total of 499 known SNPs from 87 T2DM-related genes were genotyped using
germline DNA. SNPs were analyzed for significant association with T2DM using
various classification algorithms including Quest (Quick, Unbiased, Efficient,
Statistical tree), Support Vector Machine, C4.5, logistic regression, and
K-nearest neighbor.
Results: We tested these models using the complete Korean Genome and
Epidemiology Study cohort (n Z 10,038) and computed the T2DM misclassifi-
cation rates for each model. Average misclassification rates ranged at 28.2
e52.7%. The misclassification rates for the logistic and machine-learningibuted under the terms of the Creative Commons Attribution Non-Commercial License
y-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in
is properly cited.
ol and Prevention. Published by Elsevier. All rights reserved.
76 J. Lee, et alalgorithms were lower than the statistical tree algorithms. Using 1-to-1 matched
data, the misclassification rate of the statistical tree QUEST algorithm using
body mass index and SNP variables was the lowest, but overall the logistic
regression performed best.
Conclusions: The K-nearest neighbor method exhibited more robust results than
other algorithms. For clinical and genetic data, our “multistage adjustment”
model outperformed other models in yielding lower rates of misclassification. To
improve the performance of these models, further studies using warranted,
strategies to estimate better classifiers for the quantification of SNPs need to be
developed.1. Introduction
The prevalence of type 2 diabetes mellitus (T2DM)
is increasing and the disease is becoming a worldwide
epidemic [1]. T2DM is a complex disease affected by
both genetic and environmental factors. Recent genetic
association studies have provided convincing evidence
that several novel loci and specific single nucleotide
polymorphisms (SNPs) are associated with an increased
risk of T2DM [2e6]. However, whether these SNPs
have predictive value for future development of T2DM
by an individual is controversial [7,8]. Hence develop-
ment of an optimal and useful predictive model for
T2DM using both genetic and clinical data is needed,
because early prediction of T2DM can facilitate early
control of blood glucose and lead to better clinical
outcomes for patients with T2DM, or who may develop
T2DM. However, there are few reports regarding
prediction models that incorporate both genetic and
clinical data.
We developed a new risk-prediction model for T2DM
based on various statistical algorithms, and compared
our model with preexisting models in terms of the error
rate, also referred to as misclassification. We used SNPs
and clinical data derived from a large community-based
prospective cohort. The aims of this study were: (1) to
develop a predictive model of T2DM using both genetic
and clinical data; and (2) to compare the misclassifica-
tion rates of our model versus other models.2. Methods
2.1. Study population
The study samples were drawn from the Korean
Genome and Epidemiology Study (KoGES), an ongoing
prospective community-based epidemiological study in
the communities of Ansung (rural) and Ansan (urban).
From this study cohort (nZ 10,038), we selected subjects
who were aged in their 60s. From blood, it had measured
fasting glucose, insulin, 1 hour and 2 hour glucose levels
after the ingestion of 75 grams of glucose. Using these
measures, we diagnosed new T2DM. We excluded 264
subjects who were already diagnosed with T2DM usingquestionnaire and selected newly diagnosed T2DM cases
and age-matched controls from the KoGES cohort.
The diagnosis of T2DM was based on WHO criteria
[9]. Control individuals had no past history of T2DM
and had HbA1C values <5.8%.
2.2. Selection of polymorphisms in candidate
genes
Using the NCBI (National Center for Biotechnology
Information) database and published reports, we
selected 87 known candidate genes associated with
T2DM. The selected genes included 15 genes involved
in insulin metabolism, 8 genes involved in fatty acid
binding/translocation, 13 genes involved in GLUT4
translocation, and 51 others. Subjects (control and
T2DM) were genotyped by Taqman/Goldengate
method, and 499 SNPs in 87 genes analyzed.
The association of a given SNP with T2DM were
determined by c2 tests. We then selected significantly
associated SNPs to optimize the predictive model and
summarized the associations with allele types (domi-
nant, recessive, heterozygous). Subsequently, we
generated predictive models for T2DM using selected
SNPs and clinical data. We then tested these models
using data on the original study cohort (nZ 10,038) and
computed the misclassification rates for each model.
2.3. Statistical and classification analysis
methods
We used a statistical decision tree classification
algorithm to select SNPs because of the difficulty in
optimizing high-risk SNPs.
We merged epidemiological, clinical, and genetic
data to optimize classification. We then randomly
divided the dataset into two parts, one for training or
constructing the model and the other for testing the
performance of the model (70% of the dataset was used
for training and 30% for validation). The simulations
resampled the data randomly and each simulation was
repeated 100 times. We used various classification
algorithms in this analysis based on the work of Ripley
[10], Breiman [11], Hastie [12], and Quinlan [13] as
follows. After first analyzing and screening for signifi-
cantly associated SNPs using the c2 test, we used all the
Predictive model for type 2 diabetes mellitus 77selected SNPs in various multidimensional models. The
misclassification rate of the test data was then estimated
using selected variables (SNPs).
The QUEST binary tree-growing algorithm [14]
was used for SNP selection and estimation of misclas-
sification rates (significance level Z 0.05; split
methods Z exhaustive search using Pearson’s c2;
10-fold cross-validation sample pruning).
We also analyzed another tree classification algo-
rithm first developed by Quinlan [13], C4.5, which splits
by Information Gain or Entropy Reduction (70% of the
dataset was used for training and variance reduction).
After c2 analysis of the significantly correlated SNPs,
we also used logistic regression (additive model) and K-
nearest neighbor (KNN) in Euclidean distance algorithms.
Support Vector Machines (SVMs) are machine-
learning algorithms originally developed by Hastie
[12] that provide an optimization method for forming
a separating hyperplane between cases and controls. We
also analyzed the misclassification rate using SVM-light
algorithms (regularization parameter c Z 1.0; Kernal
function Z linear).3. Results
3.1. SNP selection and predictive models using
classification
A total of 684 subjects (472 controls and 212 subjects
with T2DM) were analyzed to construct predictive
models for T2DM. The average age of the test group
subjects was 64.1  2.9 years (mean  standard devi-
ation) for controls and 64.5  2.8 years for subjects with
T2DM; the average ages of the test and control groups
were not significantly different. Supplementary Table 1
shows the baseline clinical data for the T2DM and
control subjects.
The 684 subjects were genotyped for 499 SNPs that
have previously been associated with T2DM. Among
these known 499 SNPs, 18 SNPs were significantly asso-
ciated with T2DM in our study subjects (Supplementary
Table 2).
We generated predictive models for T2DM and
calculated various misclassification rates (Supplementary
Tables 3e7). In Supplementary Tables 3e5, listing of
>1 variable indicates that the variables were treated as
covariates. For example, “BMI þ SNPs” means we have
estimated the misclassification rates when both SNPs
and body mass index (BMI) were used as variables.
Additionally, SNPs stands for the SNPs that were
significantly correlated with T2DM by c2 test. The data
in Supplementary Tables 3 and 6 were derived from all
684 subjects whereas those in Supplementary Tables 4
and 7 were derived from 1-to-1 matched data (212
controls, 212 subjects with T2DM).
In Supplementary Table 3 the misclassification rate
of the logistic algorithm using triacylglycerides (TG),BMI, and SNPs was the lowest among the five classi-
fication algorithms. The misclassification rate of the
logistic algorithm using TG, BMI, and SNPs generated
the best results because the estimated misclassification
rate was lowest (27.98  2.76) for any of the variables
and algorithms tested. However, the sensitivity was low
(19.97  8.00) in spite of the high specificity (91.29 
10.82).
Using 1-to-1 matched data, the misclassification rate
of the QUEST algorithm using both BMI and SNPs as
variables was lowest (Supplementary Table 4). The esti-
mated misclassification rate was 34.85  3.00; sensitivity
was 58.98  6.80 and specificity 71.32  6.84. Using
1-to-1 matched data and combinations of variables with
different classifiers, the estimated misclassification rates
of the five classification algorithms tested ranged at
34.85e52.69%.3.2. Model construction using multistage
adjustment model
We attempted to improve the classification results
using a multistage adjustment model. Risk factors were
selected from our previous reports that used the same
community-based cohort from the KoGES dataset. The
selected risk factors were used for clustering the data
into smaller groups with similar characteristics for
pattern recognition analysis. In the alternative multi-
stage adjustment approach, we employed simulations to
test the data. In the first stage, we selected TG and BMI
(p < 0.0001) as well-clustered variables related to
obesity. We then clustered the data by TG and BMI
values. This process gave three clusters (k Z 3). We
then ran 100 simulations for each group. The dataset
was next divided randomly into the training set (70% of
observations) and test set (30% of observations). The
first stage results are shown in Supplementary Table 5.
Group 1 contained factors associated with obesity
(BMI, waist-hip ratio [WHR], and body weight), blood
glucose levels (fasting glucose and HbA1C), total
cholesterol (TC), and homeostasis model assessment of
insulin resistance (HOMA-IR) that were all within the
normal ranges. Group 3 contained the highest BMI,
WHR, and body weight values whereas group 2 con-
tained the highest fasting glucose, HbA1C, TC, and
HOMA-IR values.
The prevalence of T2DM (in both men and women)
was similar in groups 2 and 3 but lower in group 1. In
group 1 the variables related to BMI, blood glucose
level, TC, and HOMA-IR were normal. The prevalence
of T2DM in group 2 was significantly different than in
the other two groups. In group 3 BMI, WHR, and body
weight were significantly associated with T2DM.
Figure 1 plots the distribution of each group
according to BMI, TG, and T2DM. Based on the results
of the first stage of analysis, we further compared the
classifications to assess risk factors. In Supplementary
Figure 1. Scatter diagram for each group. Control samples
are represented by Cluster 1e1, Cluster 2e1, and Cluster 3e1.
T2DM samples are represented by Cluster 1e3, Cluster 2e3,
and Cluster 3e3.
78 J. Lee, et alTables 6 and 7 the range of misclassification was from
18.30% (logistic result of Supplementary Table 6) to
54.01% (SVM result of Supplementary Table 7).
Figure 2. Model for epidemiological and clinical data.
Figure 3. Results of classification in Cluster 1.3.3. Model construction using various
classification methods
We generated an early predictive model for T2DM
based on clinical and genetic variables. However, model
construction was difficult because all factors were
highly correlated. We first used epidemiological and
clinical variables, then constructed a model using only
genetic variables (SNPs). However, if a probability
existed that any subject could be normal for clinical
factors but have abnormal genetic risk factors, the best
model would analyze all three variables. Subsequently,
we generated a model using multistage adjustments.
Figure 2 shows the result of modeling using only clinical
risk factors. Peripheral artery disease (PAD) is
a combined variable for factors related to PAD.
Figure 3, 4 and 5 show the results of the multistage
adjustment models. In Figure 3 the SNPs in TCF1_06
(HNF1 homeobox A; rs2464196) and TGFBI-01
(transforming growth factor; rs1442) are major risk
factors for T2DM. Figure 4 shows that SNPs in
MMP2_03 (matrix metallopeptidase 2; rs1030868) and
ICAM1_01 (intercellular adhesion molecule 1; rs5491)
are major risk factors for T2DM. The SNPs in
SNTG1_10 (syntrophin gamma 1; rs1911830),
FABP1_02 (fatty acid binding protein 1; rs2970901),
and FABP4_03 (fatty acid binding protein 4; rs1054135)
were also major risk factors for T2DM. For prediction
using only SNPs and the multistage adjustment model
(cluster 2), MMP2_03 was the first variable classified. In
particular, the “T/T” form of MMP2_03 was predictive
for T2DM risk.
According to the statistical and classification anal-
yses, the risk factors for T2DM were as follows: Clinical information: height, BMI, waist circumfer-
ence, blood pressure, HDL cholesterol, TC, TG, and
fasting glucose level.
 Personal and family history: hypertension, T2DM,
cerebrovascular disease, and other vascular diseases.
 SNPs: 499 SNPs in 87 candidate genes associated
with T2DM. The selected genes included 15 genes
in the insulin metabolism pathway, 8 genes in fatty
acid binding/translocation, 13 genes in GLUT4
translocation, and 51 others.
Each category is represented in a Supplementary
Table and corresponds to a field as shown in Figure 6.
Figure 4. Results of classification in Cluster 2.
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on Object Oriented Modeling. It was developed using
Fedora Core 6 and Spring’s web MVC framework,
which is written in HTML, JSF, JavaScript and Java.
MySQL was used as database to store and access the
data. The system was implemented as a web application,
and offers interfaces to input epidemiology data and
SNP values and to select models. The user can select
among different prediction models. The selected model
analyzes the user’s input values and displays predictions
about whether the input data are indicative of a person
belonging to a group at risk of developing T2DM.
Figure 7 shows a flowchart for this system.
The web interfaces consist of an epidemiology
information input page with a tabbed pane (Figure 8), an
SNP value input page, a page for selecting models, and
a page for displaying results.
4. Discussion
To construct an optimal predictive model for T2DM
we conducted various classification and clustering
analyses using clinical and genotype data. We devel-
oped predictive models for T2DM using clinical andgenotype data based on several classification algorithms.
We first analyzed the predictive significance of SNPs by
c2 test. However, when we validated the predictive
value of the models the misclassification rates were
higher than expected.
The misclassification rates were 28.24e52.69% in
the different models. In particular, in the SVM gener-
ated model the rates of misclassification, sensitivity,
and specificity were higher than in other methods. The
following reasons may explain the higher misclassifi-
cation rates obtained using this model. First, the
genotype distribution may contribute to the high level
and wide range of misclassification rates. The genotype
distribution of the 499 SNPs we investigated was
70e75% dominant genotypes (major/major allele),
5e15% recessive genotypes (minor/minor allele), and
the remainder were heterozygous genotypes (major/
minor allele). Hence the distance matrix calculation
results could be applied to all classification algorithms.
Furthermore, in analyzing the SNP pattern recognition
the results were major, minor, or heterogeneous for A,
T, G, C categorical data, which should be converted
into numerical data to measure the distance with
precision. This limitation resulted in high misclassifi-
cation rates. Thus more study is needed to transform
accurately such categorical data into numerical data.
Second, the clinical data were variable, while the
genotype data (results of the SNP association analysis)
were relatively invariable. Hence important risk factors
could appear as insignificant, resulting in a greater
misclassification rate.
In terms of high misclassification rates, similar
phenomena have been observed in predicting breast
cancer [15] and rheumatoid arthritis [13]. Schwender
et al [15] and Sun et al [13] tried to develop a predictive
model using both clinical and genotype data. Their
approach also converted the SNP allele type into
numerical data and led to high misclassification rates.
The models constructed from statistical decision-tree
classification algorithms and machine-learning methods
did not show many differences. The classifiers could be
better estimated using good quantification of SNPs. We
suggest that such genetic information in molecular
epidemiological data may be useful for classification of
individuals into groups at high or low risk for developing
T2DM. In view of our results thus far (Supplementary
Table 3) we propose that subjects with group 1 charac-
teristics can develop characteristics represented by
group 3 and, subsequently, develop those represented by
group 2. The risk factors for T2DM in group 1 were in
normal ranges whereas group 3 exhibited an increase in
values of variables related to obesity (BMI and blood
glucose) and group 2 in those related to lipid, blood
glucose, and cholesterol. The overall prevalence of
T2DM in group 2 was higher than in the other groups.
The prevalence of T2DM observed in groups 1, 2, and
3 was 20%, 47%, and 40%, respectively. BMI and WHR
Figure 5. Results of classification in Cluster 3.
80 J. Lee, et alwere: group 1 < group 2 < group 3. HbA1C were: group
1 < group 3 < group 2. HbA1C increased in tandem
with BMI (Supplementary Table 5). Thus the disease
state risk factors appeared to progress from group 1 to
group 3 to group 2 characteristics.
These results were validated by measuring several
biological parameters. For example, fasting glucoseFigure 6. Database schema for input values.
Figure 7. Web application flowchart for the early prediction
system.
Figure 8. Snapshot of T2DM web application showing the interface for entering epidemiology data.
Predictive model for type 2 diabetes mellitus 81level in group 2 was higher than in group 3. BMI values
were higher in group 3 than in group 2. A comparison of
group 3 versus group 2 demonstrated increases in fasting
glucose levels and weight.5. Conclusions
We developed predictive models for T2DM using
clinical and genotype data. However, the misclassifica-
tion rates were higher than expected. To improve the
performance of the models, further studies using large
sample sizes are warranted, and better research strate-
gies to integrate genotype data classifiers need to be
developed, particularly to quantify accurately the high-
risk SNPs.
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